| scholarly article | Q13442814 |
| P2093 | author name string | A Suzuki | |
| M Yamada | |||
| T Endo | |||
| T Kamataki | |||
| K Fujita | |||
| T Nohmi | |||
| H Kushida | |||
| P2860 | cites work | Relevance of nitrosamines to human cancer | Q34258313 |
| Construction and characterization of mutants of Salmonella typhimurium deficient in DNA repair of O6-methylguanine | Q35581164 | ||
| The colorimetric estimation of formaldehyde by means of the Hantzsch reaction | Q39224472 | ||
| Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. | Q39641695 | ||
| Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC | Q40438424 | ||
| P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. | Q41142872 | ||
| Stable expression of human CYP2E1 in Chinese hamster cells: high sensitivity to N,N-dimethylnitrosamine in cytotoxicity testing | Q41175998 | ||
| Mutagenic activity and specificity of N-nitrosomethylaniline and N-nitrosodiphenylamine in Salmonella | Q41375113 | ||
| The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium | Q42247560 | ||
| Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes | Q44524934 | ||
| Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj | Q45077642 | ||
| Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse | Q46192761 | ||
| Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation | Q46603479 | ||
| Revised methods for the Salmonella mutagenicity test | Q50211560 | ||
| Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes. | Q52558303 | ||
| Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. | Q54652897 | ||
| Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes | Q57726192 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| P304 | page(s) | 1227-1232 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. | |
| P478 | volume | 21 |
| Q44049307 | A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma |
| Q35572787 | Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus |
| Q36499756 | Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation |
| Q37232322 | Applications of CYP-450 expression for biomonitoring in environmental health |
| Q40159175 | Assessment of the application of bioanalytical tools as surrogate measure of chemical contaminants in recycled water. |
| Q43620469 | Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures |
| Q45766133 | CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis |
| Q30520640 | Contributions of human enzymes in carcinogen metabolism |
| Q43815526 | Cytochrome b(5) coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium |
| Q51370536 | Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers. |
| Q50079014 | Detection of gentoxicity of benzidine and its derivatives with the Escherichia coli DJ 702 lacZ reversion mutagenicity assay. |
| Q28075300 | Development and progress for three decades in umu test systems |
| Q34975657 | Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung |
| Q35035524 | Genetically-engineered bacteria expressing human enzymes and their use in the study of mutagens and mutagenesis |
| Q47160812 | High Level of Tobacco Carcinogen-Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers. |
| Q35654609 | Lack of Modifying Effects of Intratracheal Instillation of Quartz or Dextran Sulfate Sodium (DSS) in Drinking Water on Lung Tumor Development Initiated with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Female A/J Mice |
| Q40613245 | Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer. |
| Q43766068 | Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase |
| Q34819192 | Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. |
| Q32103802 | Summary of information on human CYP enzymes: human P450 metabolism data |
| Q43722164 | The effectiveness of the O(6)-alkylguanine-DNA alkyltransferase encoded by the ogt(ST) gene from S. typhimurium in protection against alkylating drugs, resistance to O(6)-benzylguanine and sensitisation to dibromoalkane genotoxicity |
| Q44380701 | Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors |
| Q47163198 | Variation in CYP2A6 Activity and Personalized Medicine |
| Q46096667 | When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials |
Search more.